P-selectin glycoprotein ligand-1 VNTR polymorphisms and risk of thrombosis in the antiphospholipid syndrome

Annals of the Rheumatic Diseases

Volumn 66, Issue 10, 2007, Pages 1378-1380

  Diz Kucukkaya, Revhan ^a,d   Inanc, Murat ^a   Afshar Kharghan, Vahid ^b   Zhang, Q Ed ^b   López, José A ^c   Pekcelen, Yuksel ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

P SELECTIN GLYCOPROTEIN LIGAND 1;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOSIS; VARIABLE NUMBER OF TANDEM REPEAT;

ADOLESCENT; ADULT; ANTIPHOSPHOLIPID SYNDROME; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MINISATELLITE REPEATS; POLYMORPHISM, GENETIC; RISK FACTORS; THROMBOSIS;

EID: 34848821297     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.075945     Document Type: Article

References (13)

1. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 1999;42:1309-11.
2. Levine J, Branch W, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;346:752-63.
3. Amengual O, Atsumi T, Kahmashta MA. Tissue factor in antiphospholipid syndrome: shifting the focus from coagulation to endothelium. Rheumatology 2003;42:1029-31.
4. Blank M, Shoenfeld Y, Cabilly S, Heldman Y, Fridkin M, Katchalski-Katzir E. Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides. Proc Natl Acad Sci USA 1999;96:5164-8.
5. Pierangeli SS, Espinola RG, Liu X, Harris EN. Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin. Circ Res 2001;88:245-50.
6. McEver RP, Cummings RD. Perspective series: cell adhesion in vascular biology: role of PSGL-1 bindings to selectins in leukocyte recruitment. J Clin Invest 1997;100:485-91.
7. Afshar-Kharghan V, Diz-Kucukkaya R, Ludwig EH, Marian AJ, López JA. Human polymorphism of P-selectin glycoprotein ligand-1 attributable to variable numbers of tandem decameric repeats in the mucinlike region. Blood 2001;97:3306-7.
8. Furie B, Furie BC. Thrombus formation in vivo. J Clin Invest 2005;115:3355-62.
9. Myers D, Wrobleski S, Londy F, Fex B, Hawley A, Schaub R, et al. New and effective treatment of experimentally induced venous thrombosis with antiinflammatory rPSGL-Ig. Thromb Haemost 2002;87:374-82.
10. Falati S, Liu Q, Gross P, Merrill-Skoloff G, Chou J, Vandendries E, et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand-1 and platelet P-selectin. J Exp Med 2003;197:1585-98.
11. Lozano ML, Gonzales-Conejero R, Corral J, Rivera J, Iniesta JA, Martinez C, et al. Polymorphisms of P-selectin glycoprotein ligand-1 are associated with neutrophil-platelet adhesion and with ischaemic cerebrovascular disease. Br J Haematol 2001;115:969-76.
12. Roldan V, Gonzales-Conejero R, Marin F, Pineda J, Vicente V, Corral J. Short alleles of P-selectin glycoprotein ligand-1 protect against premature myocardial infarction. Am Heart J 2004;148:602-5.
13. Tregouet DA, Barbaux S, Poirier O, Blankenberg S, Bickel C, Escolano S, et al. SELPG gene polymorphisms in relation to plasma SELPG levels and coronary artery disease. Ann Hum Genet 2003;67:504-11.